Follow on Google News News By Tag * Pharmaceutical * Drug * Clinical * Dollar * Currency * Hospitals * Healthcare * Aspen * Cagr * Strongest * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Study Published: South Africa Pharmaceuticals & Healthcare Report Q1 2011New Healthcare research report from Business Monitor International is now available from Fast Market Research
In 2009, drug spending in South Africa reached ZAR22.49bn (US$2.68bn). In 2010, we calculate that spending will reach a value of ZAR24.56bn (US$3.37bn), posting a year-on-year (y-o-y) local currency growth of 9.2%. Patients are likely to be switching to over-the-counter (OTC) medicines given the current financial downturn, particularly as they are easier to obtain, cheaper and may postpone more expensive treatments by temporarily treating problematic symptoms. Nevertheless, patented medicines represent the largest single segment of the total market (calculated as the sum of patented, generics and OTCs) by value, at just under 62% in 2009, although this share is expected to continue to decline. By 2014, we forecast that drug spending in the country will reach ZAR35.97bn (US$6.14bn), experiencing a 2009-2014 compound annual growth rate (CAGR) of 9.85% in local currency terms and of 18.00% in US dollar terms. Over the extended 2009-2019 forecast period, we calculate that drug spending will reach a value of ZAR57.65bn (US$12.56bn) Factors other than patent expirations that will be responsible for the shaping of the market include the new set of medicine pricing regulations. Pharmaceutical product mark-ups are now calculated in a tiered pricing structure. Pharmacists can charge a larger mark-up for lower priced drugs, which incentivises them to dispense more generic drugs. The government is, in the meantime, planning on enacting a longdiscussed National Health Insurance (NHI) reform scheme. The programme is to be introduced from 2012 and will be implemented in two phases over the next 14 years. The entire population will be obliged to join the scheme, with the option to also remain in private healthcare. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - South Africa Pharmaceuticals And Healthcare Industry SWOT - South Africa Political SWOT - South Africa Economic SWOT - South Africa Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Middle East And Africa Pharmaceutical Business Environment Ratings, Q111 - Rewards - Risks South Africa - Market Summary Regulatory Regime - Table: South Africa Drug Classification System (Section 22A of the Medicines and Related Substance Act 101 of 1965) - Regulatory Developments - Table: Proposed Scope Of SAHPRA - Pharmaceutical Advertising - Intellectual Property Environment - IP Developments - Counterfeit Activity - Pricing System - Price Increases - Pricing Developments - Reimbursement System Industry Developments - Epidemiology - HIV/AIDS - Tuberculosis - Healthcare Sector - Medical Tourism - Private Healthcare Regulation - National Health Reference Price List - Health Insurance - Government Health Insurance - ARV Manufacturing And Government Tenders - Research & Development Sector - Clinical Trials - R&D Activities - Vaccines - Traditional African Medicine - Medical Devices - Table: South African Customs Classification Of Medical Devices - Regional Developments In Medical Devices Sector - Table: Aims Of PEPFAR-BD Partnership Industry Forecast Scenario - Overall Market Forecast - Table: Pharmaceutical Sales Indicators 2006-2014 - Key Growth Factors - Industry - Table: Healthcare Expenditure Trends, Historical Data and Forecasts, 2006-2014 - Key Growth Factors - Macroeconomic - Table: South Africa - Economic Activity - Prescription Drug Market Forecast - Table: Prescription Drug Sales Indicators 2006-2014 - Patented Drug Market Forecast - Table: Patented Drug Sales Indicators 2006-2014 - Generic Drug Market Forecast - Table: Generic Drug Sales Indicators 2006-2014 - OTC Medicine Market Forecast - Table: OTC Medicine Sales Indicators 2006- 2014 - Medical Device Market Forecast - Table: Medical Device Sales Indicators 2006-2014 - Pharmaceutical Trade Forecast - Table: Pharmaceutical Exports Indicators 2006-2014 - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number